Ditiomustine

This classification denotes a nitrosourea compound with the molecular formula C10H18Cl2N6O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 810O95170J, chemically known as 5,6-dithia-2,9,11-triazatridecanamide, 13-chloro-n-(2-chloroethyl)-n,11-dinitroso-10-oxo- but more generally known as ditiomustine, which bears US NIH Compound Identifier 127547. European Medicines Agency schedules Ditiomustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06334MIG. The term DITIOMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). DITIOMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule ditiomustine under HS 29309085 and SITC 51549. As of Q4 2014, DITIOMUSTINE remains US FDA's Preferred Term for this commodity. Ditiomustine bears US NLM identifiers UMLS ID C1880367 and NCI Concept Code C65443. SMILES: C(CSSCCNC(=O)N(CCCL)N=O)NC(=O)N(CCCL)N=O.